Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Press release |
22 November 2012
HIV/AIDS Intellectual property and trade Malaria Malnutrition Research and development Tropical & neglected diseases Tuberculosis Vaccines

International Medical Conference to Assess Progress and Shortcomings of Global Health Revolution for Neglected Patients

Primrose and her child Panashe as doctors confirm the seven-year-old boy is suffering from TB. Photograph by Brendan Bannon
Press release
Press release |
15 November 2012
Intellectual property and trade Tuberculosis

Standard TB test failing to detect the disease in children 93% of the time

Medical officer Neisha Mohess, scans a sample of sputum for loading into an automated molecular TB diagnostic machine called GeneXpert. Photograph by Jose Cendon
Press release
Press release |
13 November 2012
Intellectual property and trade Tuberculosis

Implementation of new test increases drug-resistant TB diagnosis while shortening treatment initiation time

Press release |
08 November 2012
Vaccines
AfricaNiger

Research results show need to tailor vaccines to improve their impact

HepC_India_SofHearingProtest_Feb2016 Photograph by MSF
Press release
Press release |
02 October 2012
HIV/AIDS Intellectual property and trade
ZimbabweThailand

MSF launches online resource for challenging unwarranted drug patents

4 min
Press release |
24 September 2012
Malaria Research and development
ChadMali

Malaria in the Sahel: 65% fewer cases thanks to preventive treatment

Press release |
18 September 2012
Intellectual property and trade Tuberculosis
South Africa

MSF calls on South African Department of Health and Medicines Control Council to fast-track the registration of bedaquiline for local use

Press release |
11 September 2012
HIV/AIDS Intellectual property and trade
India

Novartis’ six-year legal challenge against India’s pro-health patent law heads to Supreme Court

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury